LU90000I2 - Omic - Google Patents

Omic

Info

Publication number
LU90000I2
LU90000I2 LU90000C LU90000C LU90000I2 LU 90000 I2 LU90000 I2 LU 90000I2 LU 90000 C LU90000 C LU 90000C LU 90000 C LU90000 C LU 90000C LU 90000 I2 LU90000 I2 LU 90000I2
Authority
LU
Luxembourg
Prior art keywords
omic
Prior art date
Application number
LU90000C
Other languages
English (en)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11859488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90000(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of LU90000I2 publication Critical patent/LU90000I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/10—Radicals substituted by singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
LU90000C 1980-02-08 1997-01-03 Omic LU90000I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1438280A JPS56110665A (en) 1980-02-08 1980-02-08 Sulfamoyl-substituted phenetylamine derivative and its preparation

Publications (1)

Publication Number Publication Date
LU90000I2 true LU90000I2 (fr) 1997-03-04

Family

ID=11859488

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90000C LU90000I2 (fr) 1980-02-08 1997-01-03 Omic

Country Status (17)

Country Link
US (6) US4373106A (fr)
EP (1) EP0034432B1 (fr)
JP (1) JPS56110665A (fr)
AR (2) AR227533A1 (fr)
AT (1) ATE7223T1 (fr)
AU (1) AU541720B2 (fr)
CA (1) CA1177849A (fr)
DE (2) DE19675042I2 (fr)
ES (1) ES499224A0 (fr)
GR (1) GR73827B (fr)
IE (1) IE50862B1 (fr)
LU (1) LU90000I2 (fr)
MX (2) MX6859E (fr)
NL (1) NL950014I2 (fr)
PT (1) PT72460B (fr)
SU (3) SU1082320A3 (fr)
UA (3) UA5980A1 (fr)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
EP0091749A3 (fr) * 1982-04-08 1984-12-05 Beecham Group Plc Dérivés de l'éthanolamine, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPS62114952A (ja) * 1985-11-13 1987-05-26 Yamanouchi Pharmaceut Co Ltd 置換フエネチルアミン誘導体の製造法
JPH066565B2 (ja) * 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
US4971990A (en) * 1988-02-19 1990-11-20 Hokuriku Pharmaceutical Co., Ltd. Phenoxyethylamine derivatives, for preparing the same and composition for exhibiting excellent α1 -blocking activity containing the same
ES2058807T3 (es) * 1989-09-04 1994-11-01 Yamanouchi Pharma Co Ltd Un metodo para la preparacion de un preparado para su administracion externa.
US5288759A (en) * 1992-08-27 1994-02-22 Alcon Laboratories, Inc. Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
WO1995002419A1 (fr) * 1993-07-14 1995-01-26 Yamanouchi Pharmaceutical Co., Ltd. Remede agissant contre le dysfonctionnement urinaire associe a l'hypertrophie de la prostate
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
IL126474A (en) * 1996-04-12 2001-03-19 Beth Israel Hospital Diabetic supplement bar
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
WO1999057131A1 (fr) * 1998-05-06 1999-11-11 Duke University Methode de traitement des affections du bas appareil urinaire et de la vessie
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
KR100648869B1 (ko) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
WO2001010436A1 (fr) * 1999-08-09 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicinales destinees au traitement de l'uropathie inferieur
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
KR100421508B1 (ko) * 2001-08-07 2004-03-09 김정한 항균 및 항진균 활성을 갖는 신규한 펜에틸아민 유도체와이의 염
US6835853B2 (en) 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
DK1443917T3 (da) * 2001-11-07 2006-07-17 Synthon Bv Tamsulosintabletter
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
RS92304A (en) 2002-04-24 2006-10-27 Boehringer Ingelheim Pharma Gmbh. & Co.Kg. Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention
US6894188B1 (en) 2002-04-30 2005-05-17 Ranbaxy Laboratory Limited Tamsulosin derivative
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
WO2004016582A1 (fr) * 2002-08-14 2004-02-26 Natco Pharma Limited Procede ameliore de preparation de chlorhydrate de tamsulosine
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US7018658B2 (en) 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
BR0316572A (pt) 2002-12-13 2005-10-04 Warner Lambert Co Ligando alfa-2-delta para o tratamento de sintomas do trato variáveis inferior, utilização e produto deste
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
DK1603866T3 (da) * 2002-12-26 2009-06-29 Cadila Healthcare Ltd Fremgangsmåde til fremstilling af enantiomerrent (R)- eller (S)-5-(2-aminopropyl)-2-methoxybenzensulfonamid
KR100503639B1 (ko) 2003-02-12 2005-07-26 보령제약 주식회사 탐술로신의 정제 방법
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
DE10315702A1 (de) * 2003-04-07 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Arzneitmittelkombinationen zur Behandlung von gutartiger Prostatahyperplasie oder zur Behandlung von abakterieller Prostatitis
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
OA13174A (en) * 2003-05-30 2006-12-13 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors.
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US20050106253A1 (en) * 2003-11-13 2005-05-19 Platteeuw Johannes J. Pharmaceutical pellets comprising tamsulosin
CA2451175A1 (fr) * 2003-11-26 2005-05-26 Torcan Chemical Ltd. Procede de preparation du tamsulosin
JP2007513943A (ja) * 2003-12-09 2007-05-31 シージェイ コーポレーション 光学的に純粋なフェネチルアミン誘導体の調製方法
SI21655A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska dru�ba d.d. Sinteza optično čistega (R)-5-(2-aminopropil)-2-metoksibenzensulfonamida
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
WO2006004093A1 (fr) * 2004-07-07 2006-01-12 Hamari Chemicals, Ltd. Procédé servant à produire un dérivé de phénylpropylamine optiquement actif
CN100545148C (zh) * 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) * 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
EP1827404A2 (fr) * 2004-12-13 2007-09-05 Boehringer Ingelheim Pharmaceuticals Inc. Utilisation de bloqueurs adrenergiques alpha pour traiter la dysmenorrhee
ES2258394B1 (es) * 2004-12-31 2007-12-01 Quimica Sintetica, S.A. Procedimiento enzimatico para la preparacion de un compuesto intermedio y su uso en la sintesis de tamsulosina clorhidrato.
US7618972B2 (en) * 2005-03-21 2009-11-17 Pfizer Inc Substituted triazole derivatives as oxytocin antagonists
US20080214622A1 (en) * 2005-03-21 2008-09-04 Alan Daniel Brown Substituted Triazole Derivatives As Oxytocin Antagonists
CA2607809A1 (fr) * 2005-05-04 2007-01-11 Medichem, S.A. Procede de preparation de tamsulosine
WO2006134212A2 (fr) * 2005-06-15 2006-12-21 Fermion Oy Procede de cristallisation
EP1917257A1 (fr) * 2005-08-10 2008-05-07 Pfizer Limited Derives de triazole substitues en tant qu'antagonistes d'oxytocine
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
WO2007031823A1 (fr) * 2005-09-12 2007-03-22 Aurobindo Pharma Limited Procédé amélioré servant à préparer du chlorhydrate de tamsulosine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
CA2627599A1 (fr) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Procede de preparation de sel hemicalcique d'acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
WO2007131804A1 (fr) 2006-05-17 2007-11-22 Synthon B.V. Composition en comprimé pour la libération prolongée de la tamsulosine
JP2009543773A (ja) * 2006-07-14 2009-12-10 ランバクシー ラボラトリーズ リミテッド ＨＭＧ−ＣｏＡレダクターゼ阻害剤の多形体及びその使用
CN101547696A (zh) * 2006-08-08 2009-09-30 奥斯拜客斯制药有限公司 具有α肾上腺素能阻断效应的取代喹唑啉化合物的制备和应用
US20080113030A1 (en) * 2006-11-09 2008-05-15 Ching-Fen Hsiao Sustained release tamsulosin formulations
CN101190890B (zh) 2006-11-30 2011-04-27 江苏豪森药业股份有限公司 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
CA2697137A1 (fr) 2007-07-20 2009-01-29 Astellas Pharma Inc. Composition pharmaceutique pour une amelioration du symptome des voies urinaires inferieures associe a une prostatomegalie
CA2709727A1 (fr) 2007-12-21 2009-07-02 Astellas Pharma Inc. Composition pharmaceutique utilisee pour attenuer les symptomes du tractus urinaire inferieur
EP2181707A1 (fr) 2008-11-04 2010-05-05 Astellas Ireland Co., Ltd. Utilisation combinée d'un antagoniste de récepteur alpha-adrénergique et d'un agent anti-muscarinique
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
PL2394648T3 (pl) 2009-02-04 2016-12-30 Kompozycja farmaceutyczna do podawania doustnego
EP2255793A1 (fr) 2009-05-28 2010-12-01 Krka Tovarna Zdravil, D.D., Novo Mesto Composition pharmaceutique comprenant du tamsulosine
WO2011046853A1 (fr) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Récipients pour compositions comprenant du méloxicam
CN102050766B (zh) * 2009-11-03 2013-08-07 安徽省新星药物开发有限责任公司 一种盐酸氨磺洛尔的合成方法
WO2011107150A1 (fr) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Utilisation de méloxicam pour le traitement à long terme de troubles musculo-squelettiques chez les chats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012110092A1 (fr) 2011-02-17 2012-08-23 Synthon Bv Dérivés de tamsulosine
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
BR102013020508B1 (pt) 2013-08-12 2021-01-12 Ems S/A. Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
CN106478467B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 制备稳定的盐酸坦索罗辛的方法
EP4035660A1 (fr) 2017-10-17 2022-08-03 Synthon B.V. Comprimés comprenant de la tamsulosine et solifénacine
EP3473244A1 (fr) 2017-10-20 2019-04-24 Veru Inc. Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
EP3473245A1 (fr) 2017-10-20 2019-04-24 Veru Inc. Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
CN108037196B (zh) * 2017-11-23 2020-06-23 中山奕安泰医药科技有限公司 一种3-硝基-4-[[(四氢-2h-吡喃-4-基)甲基]氨基]苯磺酰胺的检测方法
EA202191892A1 (ru) 2019-01-18 2022-02-24 Астразенека Аб Ингибиторы pcsk9 и способы их применения

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
ES373606A1 (es) * 1968-11-18 1972-06-01 Pfizer Un procedimiento para la preparacion de nuevos derivados depropanolamina.
US3878212A (en) * 1970-04-28 1975-04-15 Clemens Rufer Blood sugar lowering sulfamoyl pyrimidines and asymmetrical carbon atom
US4137328A (en) * 1970-07-18 1979-01-30 Pfizer Inc. Phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives as heart stimulants
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
US3860647A (en) * 1973-08-20 1975-01-14 Smithkline Corp {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines
GB1593651A (en) * 1977-02-03 1981-07-22 Allen & Hanburys Ltd Amides
CA1147342A (fr) * 1977-10-12 1983-05-31 Kazuo Imai Procede de preparation de nouveaux derives de la phenylethanolamine
JPS5553262A (en) * 1978-10-17 1980-04-18 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative
JPS5553261A (en) * 1978-10-17 1980-04-18 Yamanouchi Pharmaceut Co Ltd New phenylethanolamine derivative and its preparation
JPS606330B2 (ja) * 1978-11-30 1985-02-18 山之内製薬株式会社 α・β両遮断剤
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
DE3110573A1 (de) * 1981-03-18 1982-10-21 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n- und o-substituierten di- und/oder polyurethanen
JPS5950671B2 (ja) * 1982-08-26 1984-12-10 山之内製薬株式会社 フェニルエタノ−ルアミン誘導体およびその製造法
US4558106A (en) * 1983-03-29 1985-12-10 Union Carbide Corporation Polymerization process using metal formate to reduce the color of thermoplastic copolymers

Also Published As

Publication number Publication date
ES8201966A1 (es) 1982-01-01
UA5980A1 (uk) 1994-12-29
EP0034432B1 (fr) 1984-04-25
US4868216A (en) 1989-09-19
US4703063A (en) 1987-10-27
DE3163257D1 (en) 1984-05-30
MX6859E (es) 1986-09-08
ATE7223T1 (de) 1984-05-15
IE50862B1 (en) 1986-08-06
SU1082320A3 (ru) 1984-03-23
SU1181540A3 (ru) 1985-09-23
JPS6252742B2 (fr) 1987-11-06
DE19675042I2 (de) 2001-06-13
SU1248533A3 (ru) 1986-07-30
AR230433A1 (es) 1984-04-30
ES499224A0 (es) 1982-01-01
UA5981A1 (uk) 1994-12-29
CA1177849A (fr) 1984-11-13
EP0034432A3 (en) 1982-03-24
US4987152A (en) 1991-01-22
IE810236L (en) 1981-08-08
GR73827B (fr) 1984-05-04
JPS56110665A (en) 1981-09-01
NL950014I2 (nl) 1997-01-06
US4761500A (en) 1988-08-02
NL950014I1 (nl) 1996-12-02
PT72460A (en) 1981-03-01
EP0034432A2 (fr) 1981-08-26
AR227533A1 (es) 1982-11-15
UA5990A1 (uk) 1994-12-29
PT72460B (en) 1982-02-04
AU6689681A (en) 1981-08-13
US4373106A (en) 1983-02-08
MX9203592A (es) 1992-07-31
US4731478A (en) 1988-03-15
AU541720B2 (en) 1985-01-17

Similar Documents

Publication Publication Date Title
LU90000I2 (fr) Omic
BE887534A (fr) Sandwichpaneelelement
BE889577A (nl) Golfvormsynthese
BE891422A (fr) Degrilleur
BR8107326A (pt) Container-tanque
BR8101718A (pt) Microcentrais
BE889192A (fr) Recolteuse-hacheuse
BE889004A (nl) Grijper
BR8108640A (pt) Filatorio
BR8108621A (pt) Arpeu
IT1136619B (it) Agenti antidiarroici
BE889708A (fr) Sous-soleuse
BE890439A (fr) Afdekbaanrol
BE890703A (fr) Robinet-vanne
BE891654A (fr) Schuifdeur
BE888818A (fr) Telerupteur
BE887835A (fr) Fluidumsysteem
DK167681A (da) Kombinationselektrode
FI824224A0 (fi) Kombinerat redskap
AR219450A1 (es) Portasachet
BR6000467U (pt) Cama-mesa-poltrona
BR8002799A (pt) Corredica
BR6000440U (pt) Ferramenta saca-formas
BR6000288U (pt) Chopeira
BR6000647U (pt) Palmilha